Full name
INSTYTUT BIOMED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.90.D - Paramedical activities
11 - Manufacture of beverages
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
46.1 - Wholesale on a fee or contract basis
47.1 - Retail sale in non-specialised stores
47.2 - Retail sale of food, beverages and tobacco in specialised stores
47.7 - Retail sale of other goods in specialised stores
55 - Accommodation
56 - Food and beverage service activities
86.2 - Medical and dental practice activities
2020 | 2021 | 2022 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -15,8 | -28,2 | -76,6 | -172,1 |
EBITDA | -15,8 | -28,2 | -76,6 | -172,1 |
Short time liabilities | 1,9 | 5,6 | 0,2 | -95,7 |
Equity capital | -111,4 | -139,6 | -216,2 | -54,9 |
Operating profit (EBIT) | -15,8 | -28,2 | -76,6 | -172,1 |
Assets | 3,5 | 1,1 | 0,8 | -30,8 |
Net profit (loss) | -15,8 | -28,2 | -76,6 | -172,1 |
Cash | 3,5 | 1,1 | 0,8 | -30,8 |
Net income from sale | 4,5 | 13 | 23,5 | 81,4 |
Liabilities and provisions for liabilities | 114,9 | 140,7 | 217 | 54,2 |
Working assets | 3,5 | 1,1 | 0,8 | -30,8 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 14,2 | 20,2 | 35,4 | 15,2 |
Equity capital to total assets | -3217,9 | -12 692,7 | -28 402,7 | -15 710 |
Gross profit margin | -352,6 | -217,2 | -325,8 | -108,6 |
EBITDA Margin | -352,6 | -217,2 | -325,8 | -108,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 154 | 157 | 4 | -153 |
Net dept to EBITDA | 0,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane